SNMMI's communications staff is available to handle your inquiries, arrange interviews with experts, provide copies of research articles and more.
For assistance, please contact Kimberly Brown, associate director of public relations, at firstname.lastname@example.org or at (703) 652-6773.
SNMMI is dedicated to being the premier source of information on nuclear medicine and molecular imaging. SNMMI's online newsroom provides reporters with the information needed to write articles and gain background information on the many topics related to molecular imaging and therapy and nuclear medicine.
SNMMI issues press releases on new research, society updates and industry news for members of the press. Check back frequently to see what's new with SNMMI.
View press releases on the latest research and news from SNMMI.
Nuclear and molecular imaging are vital elements of today's medical practice, adding an additional dimension to diagnosis that can change the way diseases are understood and treated. Nuclear medicine therapies treat specific diseases, such as lymphoma or thyroid cancer, by allowing a high dose of medicine to be delivered directly to a tumor or problem area. SNMMI's fact sheets explain how nuclear medicine and molecular imaging can help diagnose and/or treat a wide range of diseases.
SNMMI publishes two peer-reviewed medical journals—The Journal of Nuclear Medicine (JNM) and The Journal of Nuclear Medicine Technology (JNMT)—which feature the latest in molecular imaging research. JNM and JNMT are the most widely read peer-reviewed publications in molecular imaging, nuclear medicine and allied disciplines.
Every month, JNM brings readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research. JNM's Newsline offers in-depth reporting on news affecting every facet of the field—the latest scientific events, government decisions, industry developments, socio-economic trends, and a broad selection of reviews from the literature.
Published quarterly, JNMT focuses on technology, quality assurance, radiation safety, and the clinical applications of nuclear medicine. Each issue features continuing education articles written by leading educators in nuclear medicine technology as well as news and updates on practice, licensure, and credentialing for nuclear medicine technologists. Practitioners from across the imaging sciences turn to JNMT for peer-reviewed information related to daily clinical practice.
SNMMI can connect you with subject-matter experts on a variety of topics who are ready to respond to tight deadlines. Contact Kimberly Brown, SNMMI's associate director of public relations, at email@example.com or at (703) 652-6773, to set up an interview with SNMMI's leadership or with one of its many experts on oncology, brain disease, heart disease, radiopharmaceuticals, reimbursement and more.
Join SNMMI on our social media networks to stay updated on the latest from the society and the nuclear medicine and molecular imaging field.
SNMMI 2014 Annual Meeting News, Announcements, Research
June 7-11, St. Louis, Mo.
St. Louis Convention Center
Scientific Research (All releases embargoed until Monday, June 9, 2014, at 12:30 pm EDT)
General Clinical Specialties
Instrumentation and Data Analysis
Molecular Targeting Probes
Oncology - Basic
Oncology - Clinical
SNMMI Image of the Year (Release embargoed until Monday, June 9, 2014, at 12:30 pm EDT)
SNMMI/SNMMI-TS Officers (All releases embargoed until Monday, June 9, 2014, at 11:00 am EDT)
SNMMI Elects Peter Herscovitch, MD, FACP, FRCPC, as President During 2014 Annual Meeting
SNMMI Elects Hossein Jadvar, MD, PhD, MPH, MBA, FACNM, as President-Elect During 2014 Annual Meeting
SNMMI Elects Sally W. Schwarz, MS, RPh, BCNP, as Vice President-Elect During 2014 Annual Meeting
SNMMI Announces April Mann, MBA, CNMT, NCT, RT(N), FSNMMI-TS, as President of Technologist Section during 2014 Annual Meeting
SNMMI Announces Aaron Scott, MIS, CNMT, NMAA, FSNMMI-TS, as President-Elect of Technologist Section During 2014 Annual Meeting
Barry A. Siegel, MD, Receives 2014 Benedict Cassen Prize for Research in Nuclear Medicine (Embargoed until Monday, June 9, 2014, at 10:00 am EDT)
F-18 Flutemetamol (F-18 Flute) alone has been used to procure positive or negative results in visual interpretations of beta-amyloid in the brain as a tool to aid in the diagnosis and study of Alzheimer’s disease. Quantitative analysis could further supercharge this technique by bringing in more data about regional and total tracer uptake, according to a study published Aug. 21 in the Journal of Nuclear Medicine .
(MI: Making a Difference)
If you don’t personally live with dyslexia, it’s likely you know someone who does. What was once a largely misunderstood condition is now recognized as being a true neurological disability, and a recent study took this understanding one step further.
(MI: Making a Difference)
In a direct visual and quantitative comparison of F-18 FET and F-18 DOPA in primary glioma, FET provided more quantitative characterization, but both were successful for tumor delineation, according to a review published Aug. 14 in the Journal of Nuclear Medicine.
(SNMMI in the News)
Medical Diagnostics: Using a handheld Raman scanner and a nanoparticle contrast agent, surgeons can remove more tumor tissue in mice than with standard methods
(MI: Making a Difference)
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.
SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis.